Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Artelo Biosciences, Inc. is a biopharmaceutical company in the growth stage. The company is focused on developing and commercializing therapeutics that modulate the endocannabinoid system. With a promising pipeline of innovative drug candidates, Artelo Biosciences is steadily advancing towards becoming a key player in the biopharmaceutical industry. The company's strategic approach to drug development and its commitment to scientific excellence have positioned it as a competitive force in the market. As Artelo Biosciences continues to expand its portfolio and invest in groundbreaking research, it is poised for continued growth and success in the biopharmaceutical sector.
Artelo Biosciences has achieved significant milestones in its history that underscore its progress and potential for success. The company has seen remarkable revenue growth as a result of successful partnerships and innovative drug development initiatives. Market penetration has been a key focus for Artelo Biosciences, with the company expanding its reach and establishing a strong presence in the biopharmaceutical market. Additionally, Artelo Biosciences has experienced substantial growth in its customer base, demonstrating the increasing demand for its innovative products and therapeutics.
Artelo Biosciences has been involved in numerous significant projects and case studies that highlight the impact and relevance of its work in the biopharmaceutical industry. The company's research and development efforts have led to the successful development of novel drug candidates with the potential to address unmet medical needs. These case studies showcase the effectiveness and versatility of Artelo Biosciences' approach to drug discovery and development, emphasizing the company's commitment to improving patient outcomes and advancing the field of biopharmaceuticals.
-
Active
Health Care/Life Sciences
505 Lomas Santa Fe Suite 160 Solana Beach California 92075 United States...
United States
7
Steven Kelly (Independent Director)
Gregory D. Gorgas (President, CEO, CFO, Secretary & Treasurer)
Steven D. Reich (Chief Medical Officer)
Andy Yates (Chief Scientific Officer & Senior Vice President)
-
$0.00
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDCAiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
-
Health Care/Life Sciences
505 Lomas Santa Fe Suite 160 Solana Beach California 92075 United States...
United States
7+
-
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC